Chen Schor Insider Profile

4 Followers
Chen Schor, President & CEO, Director at Madrigal Pharmaceuticals, holds 305.66K shares in Adicet Bio (Ticker: ACET), holds 125.56K shares in Brainstorm Cell Therapeutics (Ticker: BCLI), holds 300.00K shares in Madrigal Pharmaceuticals (Ticker: MDGL).
tipranks
Chen Schor

Chen Schor
Madrigal Pharmaceuticals (MDGL)
President & CEO, Director

Ranked #63,726 out of 99,218 Corporate Insiders

Profitable Transactions

20%
1 out of 5 Profitable Transactions

Average Return

-8.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$106M
99.48%
0.38%
0.14%
0.00%
A breakdown of Chen Schor's holdings

Insider Roles

Madrigal Pharmaceuticals
(MDGL)
President & CEO, Director
Adicet Bio
(ACET)
President & CEO, Director
Brainstorm Cell Therapeutics
(BCLI)
Director
Karyopharm Therapeutics
(KPTI)
Director
Roles that Chen Schor holds in companies

Most Profitable Insider Trade

Stock:
Adicet Bio
(ACET)
Rating:Informative Buy
Date:Oct 02, 2023 - Oct 02, 2024
Return:+13.70%
The most profitable trade made by Chen Schor

Chen Schor's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Madrigal Pharmaceuticals
Jun 08, 2015
President & CEO, Director
Uninformative Buy
$105.21M
Adicet Bio
Jan 26, 2024
President & CEO, Director
Uninformative Buy
$400.42K
Karyopharm Therapeutics
Director
Brainstorm Cell Therapeutics
Dec 21, 2018
Director
Uninformative Buy
$150.67K
List of latest transactions for each holding click on a transaction to see Chen Schor's performance on stock

Chen Schor insider profile FAQ

What is the percentage of profitable transactions made by Chen Schor?
The percentage of profitable transactions made by Chen Schor is 20%.
    What is the average return per transaction made by Chen Schor?
    The average return per transaction made by Chen Schor is -8.10%.
      What stocks does Chen Schor hold?
      Chen Schor holds: MDGL, ACET, KPTI, BCLI stocks.
        What was Chen Schor’s latest transaction?
        Chen Schor latest transaction was an Uninformative Buy of ―.
          What was Chen Schor's most profitable transaction?
          Chen Schor’s most profitable transaction was an Informative Buy of ACET stock on October 2, 2023. The return on the trade was 13.70%.
            What is Chen Schor's role in Madrigal Pharmaceuticals?
            Chen Schor's role in Madrigal Pharmaceuticals is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.